4//SEC Filing
Connelly Stephen 4
Accession 0001209191-21-060004
CIK 0001746466other
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 9:02 PM ET
Size
15.6 KB
Accession
0001209191-21-060004
Insider Transaction Report
Form 4
Connelly Stephen
DirectorPresident and CSO
Transactions
- Sale
Common Stock
2021-10-06$7.01/sh−5,625$39,418→ 993,000 total - Exercise/Conversion
Common Stock
2021-10-06$2.80/sh+2,467$6,908→ 995,467 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-10-06−5,625→ 0 totalExercise: $4.75From: 2020-12-10Exp: 2029-12-09→ Common Stock (5,625 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2021-10-06−2,467→ 0 totalExercise: $2.80From: 2021-05-19Exp: 2030-05-18→ Common Stock (2,467 underlying) - Exercise/Conversion
Common Stock
2021-10-06$4.75/sh+5,625$26,719→ 998,625 total - Sale
Common Stock
2021-10-06$7.01/sh−2,467$17,288→ 993,000 total
Footnotes (5)
- [F1]The transactions reported on this form were effected pursuant to a 10b5-1 trading plan adopted by the filer on March 31, 2021.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.05 to $7.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.06 to $7.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
- [F4]This option, representing a right to purchase twenty-five percent of the shares subject to the grant, became exercisable on December 10, 2020, which was the first anniversary of the date on which the option was granted, the remaining portion of this option vests in 36 equal monthly installments thereafter.
- [F5]This option, representing a right to purchase twenty-five percent of the shares subject to the grant, became exercisable on May 19, 2021, which was the first anniversary of the date on which the option was granted, the remaining portion of this option vests in 36 equal monthly installments thereafter.
Documents
Issuer
Equillium, Inc.
CIK 0001746466
Entity typeother
Related Parties
1- filerCIK 0001746808
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 9:02 PM ET
- Size
- 15.6 KB